Agios Reports Business Highlights and First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- On Holding sets 2029 financial targets, authorizes $1B share buyback
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Nasdaq reaches record high close, AI stocks rally
- Elmet Group signs tungsten offtake deal with Hemerdon Mine
- Meta bull case increasingly playing out, Mizuho says
Agios Pharma (AGIO) Tops Q1 EPS by 7c
May 5, 2022 7:13 AM EDTAgios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.74), $0.07 better than the analyst estimate of ($1.81). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $2.75 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More